{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:18:54Z","timestamp":1789924734554,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shanghai Science and Technology Commission","award":["10JC1414500"],"award-info":[{"award-number":["10JC1414500"]}]},{"name":"Shanghai Science and Technology Commission","award":["11DZ2260600"],"award-info":[{"award-number":["11DZ2260600"]}]},{"name":"Shanghai Committee of Science and Technology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.intimp.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T02:17:16Z","timestamp":1343096236000},"page":"217-223","source":"Crossref","is-referenced-by-count":59,"title":["Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells"],"prefix":"10.1016","volume":"14","author":[{"given":"Lin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujun","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.07.003_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of Myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2011.04.013","article-title":"Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune Myasthenia gravis symptoms","volume":"141","author":"Mu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0015","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867033456918","article-title":"Role of cytokines in neurological disorders","volume":"10","author":"Aarli Johan","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.intimp.2012.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2009.02729.x","article-title":"Changes in serum cytokine levels during plasmapheresis in patients with Myasthenia gravis","volume":"16","author":"Yeh","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0025","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for Myasthenia gravis","volume":"174","author":"Po\u00eba-Guyon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2012.07.003_bb0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2012.07.003_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.intimp.2012.07.003_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/138920207781386933","article-title":"Enjoy the silence: the story of let-7 microRNA and cancer","volume":"8","author":"Jerome","year":"2007","journal-title":"Curr Genomics"},{"key":"10.1016\/j.intimp.2012.07.003_bb0050","doi-asserted-by":"crossref","first-page":"28929","DOI":"10.1074\/jbc.M702633200","article-title":"A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2012.07.003_bb0055","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2012.07.003_bb0060","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.4049\/jimmunol.0801613","article-title":"Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes","volume":"182","author":"Alsaleh","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0065","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.0803560","article-title":"MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression","volume":"182","author":"Lu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy\u2014review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.intimp.2012.07.003_bb0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2011.04.034","article-title":"Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation","volume":"128","author":"Kumar","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein\u2013Barr virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.intimp.2012.07.003_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","article-title":"The complex role of interleukin-10 in autoimmunity","volume":"20","author":"Groux","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2012.07.003_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/msb.2010.24","article-title":"Target mRNA abundance dilutes microRNA and siRNA activity","volume":"6","author":"Arvey","year":"2010","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2012.07.003_bb0105","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1172\/JCI33099","article-title":"MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets","volume":"117","author":"van Rooij","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2012.07.003_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","article-title":"MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation","volume":"18","author":"Sonkoly","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2012.07.003_bb0120","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-08-0264","article-title":"Identification of let-7-regulated oncofetal genes","volume":"68","author":"Boyerinas","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2012.07.003_bb0125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1261\/rna.1155108","article-title":"Lin-28 interaction with the let-7 precursor loop mediates regulated microRNA processing","volume":"14","author":"Newman","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.intimp.2012.07.003_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1096\/fj.06-6130com","article-title":"Post-transcriptional regulation of the let-7 microRNA during neural cell specification","volume":"21","author":"Wulczyn","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.intimp.2012.07.003_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2012.07.003_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00002826-199304000-00002","article-title":"Pharmacological basis of immunotherapy in autoimmune diseases","volume":"16","author":"Rouveix","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(00)00385-4","article-title":"Suppression of experimental autoimmune Myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR","volume":"111","author":"Poussin","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","article-title":"Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment","volume":"24","author":"Tuzun","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2012.07.003_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2006.02.012","article-title":"Elevation of IL-12 p40 and its antibody in Myasthenia gravis with thymoma","volume":"175","author":"Yoshikawa","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0160","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in Myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(96)00152-X","article-title":"Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in Myasthenia gravis","volume":"71","author":"Matusevicius","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2012.07.003_bb0170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.1999.01062.x","article-title":"Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for Myasthenia gravis (MG)","volume":"118","author":"Huang","year":"1999","journal-title":"Clin Exp Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T23:51:41Z","timestamp":1542844301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1567576912002123"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.07.003","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}